
Anna Pagonakis
Examiner (ID: 6985)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1614, 4173, 1609, 1628, OPET |
| Total Applications | 1238 |
| Issued Applications | 444 |
| Pending Applications | 73 |
| Abandoned Applications | 723 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5705781
[patent_doc_number] => 20060194829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Therapeutic materials and methods'
[patent_app_type] => utility
[patent_app_number] => 11/312296
[patent_app_country] => US
[patent_app_date] => 2005-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11382
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194829.pdf
[firstpage_image] =>[orig_patent_app_number] => 11312296
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/312296 | Therapeutic materials and methods | Dec 19, 2005 | Abandoned |
Array
(
[id] => 6355495
[patent_doc_number] => 20100022475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'NOVEL TRIAZOLOPYRIMIDINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 11/722232
[patent_app_country] => US
[patent_app_date] => 2005-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8687
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20100022475.pdf
[firstpage_image] =>[orig_patent_app_number] => 11722232
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/722232 | NOVEL TRIAZOLOPYRIMIDINE DERIVATIVES | Dec 19, 2005 | Abandoned |
Array
(
[id] => 5522029
[patent_doc_number] => 20090030010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => '3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents'
[patent_app_type] => utility
[patent_app_number] => 11/302307
[patent_app_country] => US
[patent_app_date] => 2005-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34634
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20090030010.pdf
[firstpage_image] =>[orig_patent_app_number] => 11302307
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/302307 | 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents | Dec 13, 2005 | Issued |
Array
(
[id] => 4921586
[patent_doc_number] => 20080069901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'Therapeutic Agent for Metastatic Cancer and Cancer Metastasis Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 11/792519
[patent_app_country] => US
[patent_app_date] => 2005-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3099
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20080069901.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792519
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792519 | Therapeutic Agent for Metastatic Cancer and Cancer Metastasis Inhibitor | Dec 5, 2005 | Abandoned |
Array
(
[id] => 4823487
[patent_doc_number] => 20080227870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Carcinogen Solvents in Reducing the Carcinogen Concentration of Cells'
[patent_app_type] => utility
[patent_app_number] => 11/720029
[patent_app_country] => US
[patent_app_date] => 2005-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2292
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227870.pdf
[firstpage_image] =>[orig_patent_app_number] => 11720029
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/720029 | Carcinogen Solvents in Reducing the Carcinogen Concentration of Cells | Nov 30, 2005 | Abandoned |
Array
(
[id] => 5844410
[patent_doc_number] => 20060122162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Methods of using temozolomide formulation intrathecally in the treatment of cancers'
[patent_app_type] => utility
[patent_app_number] => 11/290779
[patent_app_country] => US
[patent_app_date] => 2005-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3806
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122162.pdf
[firstpage_image] =>[orig_patent_app_number] => 11290779
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/290779 | Methods of using temozolomide formulation intrathecally in the treatment of cancers | Nov 29, 2005 | Abandoned |
Array
(
[id] => 11789493
[patent_doc_number] => 09399030
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-26
[patent_title] => 'Topically applied circulation enhancing agent and skin and hair cosmetic and bath agent containing the same'
[patent_app_type] => utility
[patent_app_number] => 11/283931
[patent_app_country] => US
[patent_app_date] => 2005-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6351
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11283931
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/283931 | Topically applied circulation enhancing agent and skin and hair cosmetic and bath agent containing the same | Nov 21, 2005 | Issued |
Array
(
[id] => 4873702
[patent_doc_number] => 20080200436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Combination Comprising Zd6474 And An Antiandrogen'
[patent_app_type] => utility
[patent_app_number] => 11/666762
[patent_app_country] => US
[patent_app_date] => 2005-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8524
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20080200436.pdf
[firstpage_image] =>[orig_patent_app_number] => 11666762
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/666762 | Combination Comprising Zd6474 And An Antiandrogen | Oct 31, 2005 | Abandoned |
Array
(
[id] => 6426018
[patent_doc_number] => 20100168168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands'
[patent_app_type] => utility
[patent_app_number] => 11/990383
[patent_app_country] => US
[patent_app_date] => 2005-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15783
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168168.pdf
[firstpage_image] =>[orig_patent_app_number] => 11990383
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/990383 | Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands | Oct 25, 2005 | Issued |
Array
(
[id] => 5814986
[patent_doc_number] => 20060084666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor'
[patent_app_type] => utility
[patent_app_number] => 11/251982
[patent_app_country] => US
[patent_app_date] => 2005-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16497
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084666.pdf
[firstpage_image] =>[orig_patent_app_number] => 11251982
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/251982 | Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor | Oct 16, 2005 | Abandoned |
Array
(
[id] => 4916192
[patent_doc_number] => 20080096793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'Class III Slrp for the Treatment of Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/577658
[patent_app_country] => US
[patent_app_date] => 2005-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10356
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20080096793.pdf
[firstpage_image] =>[orig_patent_app_number] => 11577658
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/577658 | Class III Slrp for the Treatment of Cancer | Oct 12, 2005 | Abandoned |
Array
(
[id] => 5656495
[patent_doc_number] => 20060142231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'DNA damage repair inhibitors for treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/245735
[patent_app_country] => US
[patent_app_date] => 2005-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 17423
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20060142231.pdf
[firstpage_image] =>[orig_patent_app_number] => 11245735
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/245735 | DNA damage repair inhibitors for treatment of cancer | Oct 5, 2005 | Issued |
Array
(
[id] => 5881504
[patent_doc_number] => 20060030587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Method of treating attention deficit disorders with d-threo methylphenidate'
[patent_app_type] => utility
[patent_app_number] => 11/244924
[patent_app_country] => US
[patent_app_date] => 2005-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2593
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20060030587.pdf
[firstpage_image] =>[orig_patent_app_number] => 11244924
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/244924 | Method of treating attention deficit disorders with d-threo methylphenidate | Oct 5, 2005 | Abandoned |
Array
(
[id] => 4899865
[patent_doc_number] => 20080119479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-22
[patent_title] => 'Combination Comprising Zd6474 And Imatinib'
[patent_app_type] => utility
[patent_app_number] => 11/663913
[patent_app_country] => US
[patent_app_date] => 2005-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7755
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20080119479.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663913
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663913 | Combination Comprising Zd6474 And Imatinib | Sep 22, 2005 | Abandoned |
Array
(
[id] => 5829156
[patent_doc_number] => 20060063784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Method of using substituted pyrazolo [1,5-a] pyrimidines'
[patent_app_type] => utility
[patent_app_number] => 11/221846
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44853
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063784.pdf
[firstpage_image] =>[orig_patent_app_number] => 11221846
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/221846 | Method of using substituted pyrazolo [1,5-a] pyrimidines | Sep 8, 2005 | Abandoned |
Array
(
[id] => 112350
[patent_doc_number] => 07718801
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-18
[patent_title] => 'Substituted imidazole derivative'
[patent_app_type] => utility
[patent_app_number] => 11/661486
[patent_app_country] => US
[patent_app_date] => 2005-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72950
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/718/07718801.pdf
[firstpage_image] =>[orig_patent_app_number] => 11661486
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/661486 | Substituted imidazole derivative | Aug 29, 2005 | Issued |
Array
(
[id] => 4826884
[patent_doc_number] => 20080125428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Cancer Treatment Method'
[patent_app_type] => utility
[patent_app_number] => 11/574331
[patent_app_country] => US
[patent_app_date] => 2005-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7666
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20080125428.pdf
[firstpage_image] =>[orig_patent_app_number] => 11574331
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/574331 | Cancer Treatment Method | Aug 24, 2005 | Abandoned |
Array
(
[id] => 4932439
[patent_doc_number] => 20080003214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'Medicaments Comprising Carbonyl Compounds, And The Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/575711
[patent_app_country] => US
[patent_app_date] => 2005-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29560
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20080003214.pdf
[firstpage_image] =>[orig_patent_app_number] => 11575711
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/575711 | Medicaments Comprising Carbonyl Compounds, And The Use Thereof | Aug 23, 2005 | Abandoned |
Array
(
[id] => 5672987
[patent_doc_number] => 20060178342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease'
[patent_app_type] => utility
[patent_app_number] => 11/198663
[patent_app_country] => US
[patent_app_date] => 2005-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 24210
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178342.pdf
[firstpage_image] =>[orig_patent_app_number] => 11198663
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/198663 | Hyaluronan as a chemo-sensitizer in the treatment of cancer | Aug 4, 2005 | Issued |
Array
(
[id] => 5015704
[patent_doc_number] => 20070258912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'Use of Fluorescent Whitening Agents as Antimicrobials'
[patent_app_type] => utility
[patent_app_number] => 11/659549
[patent_app_country] => US
[patent_app_date] => 2005-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6368
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20070258912.pdf
[firstpage_image] =>[orig_patent_app_number] => 11659549
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/659549 | Use of Fluorescent Whitening Agents as Antimicrobials | Aug 2, 2005 | Abandoned |